Wird geladen...
Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer
Immune checkpoint inhibitors (ICPis) have revolutionized cancer therapy with broad activities against a wide range of malignancies. However, in many malignancies their efficacy remains limited due to the primary resistance. Furthermore, a high percentage of patients develop progression due to the se...
Gespeichert in:
| Veröffentlicht in: | Med Sci (Basel) |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6410194/ https://ncbi.nlm.nih.gov/pubmed/30678257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci7020014 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|